Abramson J, Xu R, Pecht I. An unusual inhibitory receptor–the mast cell function-associated antigen (MAFA). Mol Immunol. 2002;38(16–18):1307–13.

Article  CAS  PubMed  Google Scholar 

Butcher S, Arney KL, Cook GP. MAFA-L, an ITIM-containing receptor encoded by the human NK cell gene complex and expressed by basophils and NK cells. Eur J Immunol. 1998;28(11):3755–62.

Article  CAS  PubMed  Google Scholar 

Blaser C, Kaufmann M, Pircher H. Virus-activated CD8 T cells and lymphokine-activated NK cells express the mast cell function-associated antigen, an inhibitory C-type lectin. J Immunol. 1998;161(12):6451–4.

Article  CAS  PubMed  Google Scholar 

Beyersdorf N, Ding X, Tietze JK, Hanke T. Characterization of mouse CD4 T cell subsets defined by expression of KLRG1. Eur J Immunol. 2007;37(12):3445–54.

Article  CAS  PubMed  Google Scholar 

Borys SM, Bag AK, Brossay L, Adeegbe DO. The Yin and Yang of Targeting KLRG1(+) Tregs and Effector cells. Front Immunol. 2022;13:894508.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corral L, Hanke T, Vance RE, Cado D, Raulet DH. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur J Immunol. 2000;30(3):920–30.

Article  CAS  PubMed  Google Scholar 

Huntington ND, Tabarias H, Fairfax K, Brady J, Hayakawa Y, Degli-Esposti MA, et al. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol. 2007;178(8):4764–70.

Article  CAS  PubMed  Google Scholar 

Greenberg SA, Kong SW, Thompson E, Gulla SV. Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models. Oncotarget. 2019;10(14):1399–406.

Article  PubMed  PubMed Central  Google Scholar 

Ito M, Maruyama T, Saito N, Koganei S, Yamamoto K, Matsumoto N. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med. 2006;203(2):289–95.

Article  PubMed  PubMed Central  Google Scholar 

Müller-Durovic B, Lanna A, Covre LP, Mills RS, Henson SM, Akbar AN. Killer cell lectin-like receptor G1 inhibits NK Cell function through activation of Adenosine 5’-Monophosphate-activated protein kinase. J Immunol. 2016;197(7):2891–9.

Article  PubMed  Google Scholar 

Shi L, Wang JM, Ren JP, Cheng YQ, Ying RS, Wu XY, et al. KLRG1 impairs CD4 + T cell responses via p16ink4a and p27kip1 pathways: role in hepatitis B vaccine failure in individuals with hepatitis C virus infection. J Immunol. 2014;192(2):649–57.

Article  CAS  PubMed  Google Scholar 

Van den Bossche J, Malissen B, Mantovani A, De Baetselier P, Van Ginderachter JA. Regulation and function of the E-cadherin/catenin complex in cells of the monocyte-macrophage lineage and DCs. Blood. 2012;119(7):1623–33.

Article  PubMed  Google Scholar 

Guthmann MD, Tal M, Pecht I. A new member of the C-type lectin family is a modulator of the mast cell secretory response. Int Arch Allergy Immunol. 1995;107(1–3):82–6.

Article  CAS  PubMed  Google Scholar 

Robbins SH, Nguyen KB, Takahashi N, Mikayama T, Biron CA, Brossay L. Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells. J Immunol. 2002;168(6):2585–9.

Article  CAS  PubMed  Google Scholar 

Novelli L, Barbati C, Capuano C, Recalchi S, Ceccarelli F, Vomero M, et al. KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro. Lupus. 2023;32(4):549–59.

Article  CAS  PubMed  Google Scholar 

Yang X, Zheng Y, Han Z, Zhang X. Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy. BMC Cancer. 2021;21(1):752.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eberl M, Engel R, Aberle S, Fisch P, Jomaa H, Pircher H. Human Vgamma9/Vdelta2 effector memory T cells express the killer cell lectin-like receptor G1 (KLRG1). J Leukoc Biol. 2005;77(1):67–70.

Article  CAS  PubMed  Google Scholar 

Li Y, Li B, You Z, Zhang J, Wei Y, Li Y, et al. Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitis. J Autoimmun. 2019;103:102293.

Article  CAS  PubMed  Google Scholar 

Astorga-Gamaza A, Perea D, Sanchez-Gaona N, Calvet-Mirabent M, Gallego-Cortés A, Grau-Expósito J, et al. KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir. Cell Rep Med. 2023;4(10):101202.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li M-H, Yin W-W, Zhang Q-F, Liu Q, Li Y-L, Shao J-Y, et al. KLRG1 impairs antiviral immunity of NK-cell in individuals with chronic Hepatitis B Virus infection via the akt pathway. J Hepatol. 2017;1(66):S539–40.

Article  Google Scholar 

Assatova B, Willim R, Trevisani C, Haskett G, Kariya KM, Chopra K et al. KLRG1 cell depletion as a Novel Therapeutic Strategy in patients with mature T-cell lymphoma subtypes. Clin Cancer Res. 2024.

Xu R, Lu T, Zhao J, Wang J, Peng B, Zhang L. Identification of Tumor antigens and Immune subtypes in Lung Adenocarcinoma for mRNA Vaccine Development. Front Cell Dev Biol. 2022;10:815596.

Article  PubMed  PubMed Central  Google Scholar 

Tata A, Dodard G, Fugère C, Leget C, Ors M, Rossi B, et al. Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers. Oncoimmunology. 2021;10(1):1933808.

Article  PubMed  PubMed Central  Google Scholar 

Liu Z, Choksi S, Kwon HJ, Jiao D, Liu C, Liu ZG. Tumor necroptosis-mediated shedding of cell surface proteins promotes metastasis of breast cancer by suppressing anti-tumor immunity. Breast Cancer Res. 2023;25(1):10.

Article  PubMed  PubMed Central  Google Scholar 

Noyes D, Bag A, Oseni S, Semidey-Hurtado J, Cen L, Sarnaik AA et al. Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8 + T cells. J Immunother Cancer. 2022;10(5).

Chan IS, Knútsdóttir H, Ramakrishnan G, Padmanaban V, Warrier M, Ramirez JC et al. Cancer cells educate natural killer cells to a metastasis-promoting cell state. J Cell Biol. 2020;219(9).

Goel N, Needham M, Soler-Ferran D, Cotreau MM, Escobar J, Greenberg S, POS1342 DEPLETION, OF KLRG1 + T CELLS IN A FIRST-IN-HUMAN CLINICAL TRIAL OF ABC008 IN INCLUSION BODY MYOSITIS (IBM). Ann Rheum Dis. 2022;81(Suppl 1):10083–9.

Article  Google Scholar 

Curran MA, Kim M, Montalvo W, Al-Shamkhani A, Allison JP. Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production. PLoS ONE. 2011;6(4):e19499.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ortega E, Schneider H, Pecht I. Possible interactions between the fc epsilon receptor and a novel mast cell function-associated antigen. Int Immunol. 1991;3(4):333–42.

Article  CAS  PubMed  Google Scholar 

Voehringer D, Koschella M, Pircher H. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood. 2002;100(10):3698–702.

Article  CAS  PubMed  Google Scholar 

Zeng X, Zheng M, Liu T, Bahabayi A, Kang R, Xu Q, et al. Changes in the expression of T-cell factor-1 in follicular helper T cells reflect the condition of systemic lupus erythematosus patients. Int Immunopharmacol. 2022;108:108877.

Article  CAS  PubMed  Google Scholar 

Robbins SH, Terrizzi SC, Sydora BC, Mikayama T, Brossay L. Differential regulation of killer cell lectin-like receptor G1 expression on T cells. J Immunol. 2003;170(12):5876–85.

Article  CAS  PubMed